serena williams glp-1 medication Shares Her Weight Loss Journey With Company Ro 📄 Inside Serena Williams’ partnership

These new antiobesity medications can reach up to 24% weight loss, which makes possible an effective management of obesity and its complications

Cardiovascular protection: the SELECT trial The SELECT trial was a landmark cardiovascular outcome study that enrolled 17,604 adults with established cardiovascular disease and overweight or obesity but without diabetes

Patients should also be informed about the boxed warning regarding medullary thyroid carcinoma risk, the importance of avoiding these medications during pregnancy and lactation, and the need for appropriate monitoring if rapid improvements in blood glucose occur in patients with diabetes and retinopathy

Chen, J., Yin, D., & Dou, K

Follow us on Google and Google News.